Tucker MA - Search Results

1

Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers.

Li WQ, Pfeiffer RM, Hyland PL, Shi J, Gu F, Wang Z, Bhattacharjee S, Luo J, Xiong X, Yeager M, Deng X, Hu N, Taylor PR, Albanes D, Caporaso NE, Gapstur SM, Amundadottir L, Chanock SJ, Chatterjee N, Landi MT, Tucker MA, Goldstein AM, Yang XR. Li WQ, et al. Among authors: tucker ma. Carcinogenesis. 2014 Dec;35(12):2698-705. doi: 10.1093/carcin/bgu203. Epub 2014 Sep 19. Carcinogenesis. 2014. PMID: 25239644 Free PMC article.

2

National Cancer Institute Workshop Report: the phakomatoses revisited.

Tucker M, Goldstein A, Dean M, Knudson A. Tucker M, et al. J Natl Cancer Inst. 2000 Apr 5;92(7):530-3. doi: 10.1093/jnci/92.7.530. J Natl Cancer Inst. 2000. PMID: 10749907 No abstract available.

3

Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study.

Chatterjee N, Shih J, Hartge P, Brody L, Tucker M, Wacholder S. Chatterjee N, et al. Genet Epidemiol. 2001 Sep;21(2):123-38. doi: 10.1002/gepi.1022. Genet Epidemiol. 2001. PMID: 11507721

4

HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease.

Harty LC, Lin AY, Goldstein AM, Jaffe ES, Carrington M, Tucker MA, Modi WS. Harty LC, et al. Among authors: tucker ma. Blood. 2002 Jan 15;99(2):690-3. doi: 10.1182/blood.v99.2.690. Blood. 2002. PMID: 11781255 Free article.

5

DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma.

Landi MT, Baccarelli A, Tarone RE, Pesatori A, Tucker MA, Hedayati M, Grossman L. Landi MT, et al. Among authors: tucker ma. J Natl Cancer Inst. 2002 Jan 16;94(2):94-101. doi: 10.1093/jnci/94.2.94. J Natl Cancer Inst. 2002. PMID: 11792747 Free article.

6

Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history.

Hartge P, Chatterjee N, Wacholder S, Brody LC, Tucker MA, Struewing JP. Hartge P, et al. Among authors: tucker ma. Epidemiology. 2002 May;13(3):255-61. doi: 10.1097/00001648-200205000-00004. Epidemiology. 2002. PMID: 11964925

7

Analysis of mutations and identification of several polymorphisms in the putative promoter region of the P34CDC2-related CDC2L1 gene located at 1P36 in melanoma cell lines and melanoma families.

Feng Y, Shi J, Goldstein AM, Tucker MA, Nelson MA. Feng Y, et al. Among authors: tucker ma. Int J Cancer. 2002 Jun 20;99(6):834-8. doi: 10.1002/ijc.10422. Int J Cancer. 2002. PMID: 12115485 Free article.

8

Melanoma etiology: where are we?

Tucker MA, Goldstein AM. Tucker MA, et al. Oncogene. 2003 May 19;22(20):3042-52. doi: 10.1038/sj.onc.1206444. Oncogene. 2003. PMID: 12789279 Review.

9

Localization of a novel melanoma susceptibility locus to 1p22.

Gillanders E, Juo SH, Holland EA, Jones M, Nancarrow D, Freas-Lutz D, Sood R, Park N, Faruque M, Markey C, Kefford RF, Palmer J, Bergman W, Bishop DT, Tucker MA, Bressac-de Paillerets B, Hansson J, Stark M, Gruis N, Bishop JN, Goldstein AM, Bailey-Wilson JE, Mann GJ, Hayward N, Trent J; Lund Melanoma Study Group; Melanoma Genetics Consortium. Gillanders E, et al. Among authors: tucker ma. Am J Hum Genet. 2003 Aug;73(2):301-13. doi: 10.1086/377140. Epub 2003 Jul 3. Am J Hum Genet. 2003. PMID: 12844286 Free PMC article.

10

CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.

Rutter JL, Goldstein AM, Dávila MR, Tucker MA, Struewing JP. Rutter JL, et al. Among authors: tucker ma. Oncogene. 2003 Jul 10;22(28):4444-8. doi: 10.1038/sj.onc.1206564. Oncogene. 2003. PMID: 12853981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

443 results

Search Page